Business & funding · first seen 2h ago, updated 2h ago
Enveda Raises $311M Series E at $2B Valuation to Advance AI-Discovered Natural Medicines
Enveda, a biotech startup that uses AI to discover new drugs from the natural world, has raised a $311 million Series E at a $2 billion valuation. The round was led by Catalio Capital Management, with participation from Iconiq and other inv…
Summary from The AI Insider.